Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial-Reference-Cited by-同舟云学术

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial

Published:2013-03 Issue:2 Volume:12 Page:130-140
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Assael Baroukh M.,Pressler Tacjana,Bilton Diana,Fayon Michael,Fischer Rainald,Chiron Raphael,LaRosa Mario,Knoop Christiane,McElvaney Noel,Lewis Sandra A.,Bresnik Mark,Montgomery A. Bruce,Oermann Christopher M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health;Flume;Am J Respir Crit Care Med,2007

2. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus;Heijermann;J Cyst Fibros,2009

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic fibrosis;Nature Reviews Disease Primers;2024-08-08

2. Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: Challenges, recent advances, and future perspectives;Journal of Drug Delivery Science and Technology;2024-04

3. Macrolide antibiotics (including azithromycin) for cystic fibrosis;Cochrane Database of Systematic Reviews;2024-02-27

4. Inhaled aztreonam lysine in the management ofPseudomonas aeruginosain patients with cystic fibrosis: real-life effectiveness;European Journal of Hospital Pharmacy;2023-12-09

5. Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany;Pulmonary Pharmacology & Therapeutics;2023-06